Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Peking Union Medical College Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with pathologically confirmed pancreatic ductal adenocarcinoma.
Aged ≥18 years with an expected survival time of ≥1 month (to be assessed for the advanced cohort). Assessment criteria: Comprehensive evaluation based on the patient's radiological tumor burden, vital organ function and physical status. Specific quantitative indicators: Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2, or Karnofsky Performance Status (KPS) score of ≥60. For patients in the advanced cohort, the assessment shall be jointly confirmed by two attending physicians with the professional title of associate chief physician or above in combination with radiological examination results.
Voluntarily sign the informed consent form.
You may not be if
Complicated with other untreated malignant tumors or severe mental disorders.
Pregnant women or patients unable to cooperate with follow-up.
Clareo Health | Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
